CytoDyn Inc.
CYDY
$0.204
$0.0031.49%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | 0.00 |
| Gross Profit | -- | -- | -- | -- | 0.00 |
| SG&A Expenses | 8.44M | 9.69M | 9.71M | 10.79M | 10.55M |
| Depreciation & Amortization | 18.00K | 20.00K | 24.00K | 29.00K | 35.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.89M | 16.30M | 15.99M | 18.06M | 15.20M |
| Operating Income | -16.89M | -16.30M | -15.99M | -18.06M | -15.20M |
| Income Before Tax | -7.09M | -14.25M | -19.04M | -49.84M | -51.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.09 | -14.25 | -19.04 | -49.84 | -51.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.09M | -14.25M | -19.04M | -49.84M | -51.69M |
| EBIT | -16.89M | -16.30M | -15.99M | -18.06M | -15.20M |
| EBITDA | -16.87M | -16.28M | -15.97M | -18.03M | -15.17M |
| EPS Basic | -0.01 | -0.02 | -0.02 | -0.05 | -0.06 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.01 | -0.02 | -0.02 | -0.05 | -0.06 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 4.60B | 4.35B | 4.09B | 3.88B | 3.78B |
| Average Diluted Shares Outstanding | 4.66B | 4.42B | 4.15B | 3.88B | 3.78B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |